2 mL Hyaluronic Acid Gel
A confirmed 2 mL hyaluronic acid gel presentation with a 24 mg/mL concentration, prefilled syringe and two needle components for B2B review.
Public portfolio parameters
Current B2B portfolio baseline for initial format review.
- Net volume
- 2.0 mL per syringe
- Hyaluronic acid concentration
- 24 mg/mL
- Presentation
- Graduated prefilled syringe
- Cross-linking
- Monophasic (default); biphasic available for qualified B2B projects
- Pack components
- Two needle components, molded tray and foil pouch
- Storage
- Store at 2°C–25°C; protect from light; do not freeze.
- Shelf life
- 24 months
- Manufacturing entity
- GuangLong
Final release specifications, target-market documentation and any use claims remain subject to the qualified project review.
2 mL Prefilled-Syringe Configuration
The GuangLong 2 mL hyaluronic acid gel format is presented as one graduated prefilled syringe with two needle components. Its larger barrel and 0.5–2.0 mL scale distinguish it from the 1 mL presentation while retaining a compact tray-and-pouch configuration.
Confirmed Public Parameters
- Net volume: 2.0 mL per syringe
- Hyaluronic acid concentration: 24 mg/mL
- Primary presentation: Graduated prefilled syringe
- Pack components: Two needle components, molded tray and foil pouch
- Manufacturing entity: GuangLong
- B2B coordination: Innovision Bio
B2B Packaging Review
Project discussions can cover needle specification, tray dimensions, pouch and carton artwork, pack count and destination-market labeling. Component and document requirements are aligned to the actual buyer brief rather than inferred from the representative image.
Information Confirmed Per Project
Final formulation scope, cross-linking status, component references, sterilization records and target-market documentation are reviewed during qualification. This page does not represent a public IFU, registration or final release specification.
Project review
Before requesting project-specific information
A concise brief helps us confirm the right commercial and documentation path for your discussion.
- Identify the target market, responsible entity, and intended professional channel.
- Describe the commercial scope, packaging concept, and indicative project timing.
- State the discussion stage and whether an NDA is already in place.
- Request only the information needed for the current qualified review stage.
Project-specific materials are considered only after qualification and do not represent product approval, registration, or a public technical specification.